Skip to main navigation Skip to search Skip to main content

Emerging safety issues in alemtuzumab-treated MS patients

  • Department of Neurology, Amsterdam, Netherlands

Research output: Contribution to journalEditorialAcademicpeer-review

21 Downloads (Pure)
Original languageEnglish
Pages (from-to)1206-1208
Number of pages3
JournalMULTIPLE SCLEROSIS JOURNAL
Volume25
Issue number9
DOIs
Publication statusPublished - 1 Aug 2019

Cite this